Drugs already being used to treat high blood pressure and cholesterol could reduce the risk of Alzheimer’s disease and dementia, according to a new Schaeffer Center study of nearly 700,000 Medicare beneficiaries.
A USC-Brookings Schaeffer Initiative expert examines if the mandate meaningfully increased coverage and what can be learned from the ACA if policymakers want to achieve universal coverage in the future.
How will remanding Texas v. U.S. case to the lower court will affect the health care market? Drug manufacturers face tremendous scientific uncertainty while ACA funding has clearly become a major component in state spending.
Researchers examined data on charges for providers treating Medicare patients and compared them to Medicare’s set payment rate across specialties. They found specialties possessing the ability to surprise bill out-of-network patients higher charges relative to Medicare rates than other specialties.
In this episode of the Brookings Cafeteria podcast, health policy experts from the USC-Brookings Schaeffer Initiative discuss the presidential candidates’ health proposals, and also look at what to do about surprise medical billing.